Heritage FDA Tuesday, February 11, 2014 +0.30 Positive

FDA Approves TRANEXAMIC ACID — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has received FDA approval for the ANDA202436 for tranexamic acid, strengthening its portfolio of IV hemostatic agents. This approval positions the company to compete more directly in the market for maternal and surgical bleeding treatments by broadening availability of the generic product.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed